{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T09:32:27Z","timestamp":1771234347105,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI1201813"],"award-info":[{"award-number":["PI1201813"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-016-1729-y","type":"journal-article","created":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T07:36:04Z","timestamp":1484379364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial"],"prefix":"10.1186","volume":"18","author":[{"name":"PHN group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Rull\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana","family":"Bulilete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Leiva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aina","family":"Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Roca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Gonz\u00e1lez-Bals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Llobera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,14]]},"reference":[{"key":"1729_CR1","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1503\/cmaj.091711","volume":"182","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ. 2010;182:1731\u20136.","journal-title":"CMAJ"},{"key":"1729_CR2","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4:e004833.","journal-title":"BMJ Open"},{"key":"1729_CR3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/WNL.0b013e3182a3516e","volume":"81","author":"BP Yawn","year":"2013","unstructured":"Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013;81:928\u201330.","journal-title":"Neurology"},{"key":"1729_CR4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","volume":"157","author":"HJ Forbes","year":"2016","unstructured":"Forbes HJ, Thomas SL, Smeeth L, Clayton T, Farmer R, Bhaskaran K, et al. A systematic review and meta-analysis of risk factors for postherpetic neuralgia. Pain. 2016;157:30\u201354.","journal-title":"Pain"},{"key":"1729_CR5","doi-asserted-by":"crossref","unstructured":"Jericho B. Postherpetic neuralgia: a review. Internet J Orthop Surg. 2009;16(2). http:\/\/print.ispub.com\/api\/0\/ispub-article\/12886 .","DOI":"10.5580\/2684"},{"key":"1729_CR6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3344\/kjp.2015.28.3.177","volume":"28","author":"YH Jeon","year":"2015","unstructured":"Jeon YH. Herpes zoster and postherpetic neuralgia: practical consideration for prevention and treatment. Korean J Pain. 2015;28:177\u201384.","journal-title":"Korean J Pain"},{"key":"1729_CR7","first-page":"556","volume":"80","author":"FY Meng","year":"2014","unstructured":"Meng FY, Zhang LC, Liu Y, Pan LH, Zhu M, Li CL, et al. Efficacy and safety of gabapentin for treatment of postherpetic neuralgia: a meta-analysis of randomized controlled trials. Minerva Anestesiol. 2014;80:556\u201367.","journal-title":"Minerva Anestesiol"},{"key":"1729_CR8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archdermatol.2011.81","volume":"147","author":"W Lapolla","year":"2011","unstructured":"Lapolla W, Digiorgio C, Haitz K, Magel G, Mendoza N, Grady J, et al. Incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster: open-label study. Arch Dermatol. 2011;147:901\u20137.","journal-title":"Arch Dermatol"},{"key":"1729_CR9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/dth.12331","volume":"29","author":"EG Lee","year":"2016","unstructured":"Lee EG, Lee HJ, Hyun DJ, Min K, Kim DH, Yoon MS. Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study. Dermatol Ther. 2016;29:184\u201390.","journal-title":"Dermatol Ther"},{"issue":"(1)","key":"1729_CR10","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S1386-6532(10)70005-6","volume":"48","author":"RJ Whitley","year":"2010","unstructured":"Whitley RJ, Volpi A, McKendrick M, van Wijck A, Oaklander AL. Management of herpes zoster and post-herpetic neuralgia now and in the future. J Clin Virol. 2010;48(1):S20\u20138.","journal-title":"J Clin Virol"},{"key":"1729_CR11","unstructured":"European Medicines Agency (EMA). Guideline on the clinical development of medicinal products intended for the treatment of pain. London: EMA, Committee for Medicinal Products for Human Use (CHMP); 17 Dec 2015. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2015\/12\/WC500199242.pdf . Accessed 3 Feb 2016."},{"key":"1729_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pain.2004.12.010","volume":"114","author":"D Bouhassira","year":"2005","unstructured":"Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114:29\u201336.","journal-title":"Pain"},{"key":"1729_CR13","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","volume":"70","author":"RD Treede","year":"2008","unstructured":"Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630\u20135.","journal-title":"Neurology"},{"key":"1729_CR14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1477-7525-5-66","volume":"5","author":"C Perez","year":"2007","unstructured":"Perez C, Galvez R, Huelbes S, Insausti J, Bouhassira D, Diaz S, et al. Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component. Health Qual Life Outcomes. 2007;5:66.","journal-title":"Health Qual Life Outcomes"},{"key":"1729_CR15","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1157\/13121076","volume":"130","author":"G Vilagut","year":"2008","unstructured":"Vilagut G, Valderas JM, Ferrer M, Garin O, L\u00f3pez-Garc\u00eda E, Alonso J. Interpretation of SF-36 and SF-12 questionnaires in Spain: physical and mental components [in Spanish]. Med Clin (Barc). 2008;130:726\u201335.","journal-title":"Med Clin (Barc)"},{"key":"1729_CR16","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.medcli.2011.10.024","volume":"139","author":"S Schmidt","year":"2012","unstructured":"Schmidt S, Vilagut G, Garin O, Cunillera O, Tresserras R, Brugulat P, et al. Reference guidelines for the 12-Item Short-Form Health Survey version 2 based on the Catalan general population [in Spanish]. Med Clin (Barc). 2012;139:613\u201325.","journal-title":"Med Clin (Barc)"},{"key":"1729_CR17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ejpain.2006.05.002","volume":"11","author":"J Rejas","year":"2007","unstructured":"Rejas J, Ribera MV, Ruiz M, Masrram\u00f3n X. Psychometric properties of the MOS (Medical Outcomes Study) Sleep Scale in patients with neuropathic pain. Eur J Pain. 2007;11:329\u201340.","journal-title":"Eur J Pain"},{"key":"1729_CR18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","volume":"109","author":"R Sabatowski","year":"2004","unstructured":"Sabatowski R, G\u00e1lvez R, Cherry DA, Jacquot F, Vincent E, Maisonobe P, et al. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain. 2004;109:26\u201335.","journal-title":"Pain"},{"key":"1729_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/pds.2630010207","volume":"1","author":"RHB Meyboom","year":"1992","unstructured":"Meyboom RHB, Royer RJ. Causality classification at pharmacovigilance centres in the European Community. Pharmacoepidemiol Drug Saf. 1992;1:87\u201397.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1729_CR20","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1212\/01.WNL.0000123261.00004.29","volume":"62","author":"BF Jung","year":"2004","unstructured":"Jung BF, Johnson RW, Griffin DRJ, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology. 2004;62:1545\u201351.","journal-title":"Neurology"},{"key":"1729_CR21","first-page":"39","volume-title":"Herpes zoster and postherpetic neuralgia","author":"RH Dworkin","year":"2001","unstructured":"Dworkin RH, Schmader KE. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Watson CPN, Gershon AA, editors. Herpes zoster and postherpetic neuralgia. 2nd ed. New York: Elsevier; 2001. p. 39\u201364.","edition":"2"},{"key":"1729_CR22","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271\u201384.","journal-title":"N Engl J Med"},{"key":"1729_CR23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(06)68032-X","volume":"367","author":"AJM Wijck van","year":"2006","unstructured":"van Wijck AJM, Opstelten W, Moons KGM, van Essen GA, Stolker RJ, Kalkman CJ, et al. The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial. Lancet. 2006;367:219\u201324.","journal-title":"Lancet"},{"key":"1729_CR24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.conb.2010.05.007","volume":"20","author":"CS Bauer","year":"2010","unstructured":"Bauer CS, Tran-Van-Minh A, Kadurin I, Dolphin AC. A new look at calcium channel \u03b12\u03b4 subunits. Curr Opin Neurobiol. 2010;20:563\u201371.","journal-title":"Curr Opin Neurobiol"},{"key":"1729_CR25","doi-asserted-by":"crossref","first-page":"11230","DOI":"10.1073\/pnas.0504183102","volume":"102","author":"C Cant\u00ed","year":"2005","unstructured":"Cant\u00ed C, Nieto-Rostro M, Foucault I, Heblich F, Wratten J, Richards MW, et al. The metal-ion-dependent adhesion site in the von Willebrand factor-A domain of \u03b12\u03b4 subunits is key to trafficking voltage-gated Ca2+ channels. Proc Natl Acad Sci U S A. 2005;102:11230\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1729_CR26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12272-013-0057-y","volume":"36","author":"A Kukkar","year":"2013","unstructured":"Kukkar A, Bali A, Singh N, Jaggi AS. Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res. 2013;36:237\u201351.","journal-title":"Arch Pharm Res"},{"key":"1729_CR27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1001\/archdermatol.2011.2864","volume":"148","author":"N Fett","year":"2012","unstructured":"Fett N. Gabapentin not shown to prevent postherpetic neuralgia. Arch Dermatol. 2012;148:400\u20131.","journal-title":"Arch Dermatol"},{"key":"1729_CR28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s40257-013-0011-2","volume":"14","author":"EY Gan","year":"2013","unstructured":"Gan EY, Tian EAL, Tey HL. Management of herpes zoster and post-herpetic neuralgia. Am J Clin Dermatol. 2013;14:77\u201385.","journal-title":"Am J Clin Dermatol"},{"key":"1729_CR29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1741-7015-8-37","volume":"8","author":"RW Johnson","year":"2010","unstructured":"Johnson RW, Bouhassira D, Kassianos G, Lepl\u00e8ge A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med. 2010;8:37.","journal-title":"BMC Med"},{"key":"1729_CR30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12889-015-1514-y","volume":"15","author":"A Gater","year":"2015","unstructured":"Gater A, Uhart M, McCool R, Pr\u00e9aud E. The humanistic, economic and societal burden of herpes zoster in Europe: a critical review. BMC Public Health. 2015;15:193.","journal-title":"BMC Public Health"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1729-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:19:45Z","timestamp":1568719185000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-016-1729-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,14]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1729"],"URL":"https:\/\/doi.org\/10.1186\/s13063-016-1729-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,14]]},"article-number":"24"}}